Experimental infection of European red foxes (Vulpes vulpes) with canine herpesvirus.
We report on the pathogenicity of canine herpesvirus (CHV) for European red foxes. In the first experiment, we inoculated 10 adult foxes intravenously with a canine isolate of CHV. All foxes became infected and shed CHV in saliva and genital secretions for up to 14 days post-inoculation (p.i.) as evaluated by PCR and/or by virus isolation. All foxes developed clinical signs such as fever, lethargy and evidence of respiratory tract disease. Two foxes died on day 6 p.i., one on day 7 p.i., and one fox was euthanased on day 6 p.i. Tissues taken from the four dead foxes were positive for CHV by PCR. The remaining six foxes recovered after approximately 14 days p.i. Virus particles with morphology typical of herpesviruses were found by electron microscopy in the liver of an infected animal. All surviving foxes developed serum anti-CHV antibodies. In a second experiment, six foxes were dosed perorally with CHV and paired with six untreated controls. Neither the perorally dosed nor the in-contact control foxes developed clinical signs of disease. Infectious CHV was not isolated from any of the dosed or the in-contact foxes but all perorally-infected foxes and one of the in-contact foxes tested PCR-positive for CHV on several occasions p.i. All perorally-infected foxes, but none of the in-contact foxes, seroconverted. In summary, intravenous CHV inoculation caused a clinical disease in adult foxes much more severe than observed in experimentally-infected adult dogs. No clinical disease or virus spread was observed after peroral dosing although viral infection occurred as evidenced by seroconversion.
Reubel
G H
GH
Pest Animal Control Cooperative Research Center, CSIRO Sustainable Ecosystems, GPO Box 284, Canberra, ACT 2601, Australia. g.reubel@cse.csiro.au
Pekin
J
J
Venables
D
D
Wright
J
J
Zabar
S
S
Leslie
K
K
Rothwell
T L
TL
Hinds
L A
LA
Braid
A
A
D000284:Administration, Oral; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005589:Foxes; D006566:Herpesviridae Infections / Q000662:veterinary* / Q000821:virology; D002184:Herpesvirus 1, Canid / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity*; D007275:Injections, Intravenous / Q000662:veterinary; D008099:Liver / Q000473:pathology / Q000821:virology; D008297:Male; D008854:Microscopy, Electron / Q000662:veterinary; D016133:Polymerase Chain Reaction / Q000662:veterinary; D013997:Time Factors; D017201:Virus Shedding
D000914:Antibodies, Viral; D004279:DNA, Viral